Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 79

1.

Friend retrovirus studies reveal complex interactions between intrinsic, innate and adaptive immunity.

Dittmer U, Sutter K, Kassiotis G, Zelinskyy G, Bánki Z, Stoiber H, Santiago ML, Hasenkrug KJ.

FEMS Microbiol Rev. 2019 May 14. pii: fuz012. doi: 10.1093/femsre/fuz012. [Epub ahead of print]

PMID:
31087035
2.

Commensal and Pathogenic Bacteria Indirectly Induce IL-22 but Not IFNγ Production From Human Colonic ILC3s via Multiple Mechanisms.

Castleman MJ, Dillon SM, Purba CM, Cogswell AC, Kibbie JJ, McCarter MD, Santiago ML, Barker E, Wilson CC.

Front Immunol. 2019 Mar 29;10:649. doi: 10.3389/fimmu.2019.00649. eCollection 2019.

3.

A Protective Role for the Lectin CD169/Siglec-1 against a Pathogenic Murine Retrovirus.

Uchil PD, Pi R, Haugh KA, Ladinsky MS, Ventura JD, Barrett BS, Santiago ML, Bjorkman PJ, Kassiotis G, Sewald X, Mothes W.

Cell Host Microbe. 2019 Jan 9;25(1):87-100.e10. doi: 10.1016/j.chom.2018.11.011. Epub 2018 Dec 27.

4.

Reliability of OMERACT ultrasound elementary lesions in gout: results from a multicenter exercise.

Cazenave T, Martire V, Reginato AM, Gutierrez M, Waimann CA, Pineda C, Rosa JE, Ruta S, Sedano-Santiago O, Bertoli AM, Audisio M, Hernandez-Diaz C, Ventura-Rios L, Quintero M, De Miguel E, Alvarez-Del-Castillo-Araujo AL, Abril A, Ayala-Ledesma EN, Alarcon-Isidro E, Santiago ML, Pera MA, Urquiola C, Rodriguez Gil G, Saldarriaga Rivera LM, Cefferino C, Benegas M, Diaz Cortes ME, Bravo M, Peiteado D, Estrella NA, Micas RA, Saavedra Muñoz J, Arape Toyo RDC, Gálvez Elkin MS, Spindler WJ, Sandobal C, Marin J, Lima Gomes Ochtrop M, Pavao Ayala R, Catay ER, Py GE, Aguilar GH, Rengel Colina YY, Airoldi CA, Mora-Trujillo CS, Kohan MP, Urioste Eguez LE, Castillo-Gallego C, Diaz-Coto JF, Tate P, Saucedo CM, Vega-Hinojosa O, Troitiño CJ, Marengo MF, Marcaida PM, Monjo Henry I, Muñoz-Louis R, Solano C, Fernandez Castillo FR, Graf CE, Guinsburg M, Santa Cruz MJ, Navarta Ortiz DA, Alva Linares M, Rosemffet MG; Pan-American League of Associations for Rheumatology (PANLAR) Ultrasound Study Group.

Rheumatol Int. 2019 Apr;39(4):707-713. doi: 10.1007/s00296-018-4220-0. Epub 2018 Dec 11.

PMID:
30539275
5.

A compartmentalized type I interferon response in the gut during chronic HIV-1 infection is associated with immunopathogenesis.

Dillon SM, Guo K, Austin GL, Gianella S, Engen PA, Mutlu EA, Losurdo J, Swanson G, Chakradeo P, Keshavarzian A, Landay AL, Santiago ML, Wilson CC.

AIDS. 2018 Jul 31;32(12):1599-1611. doi: 10.1097/QAD.0000000000001863.

PMID:
29762170
6.

SAMHD1 suppresses innate immune responses to viral infections and inflammatory stimuli by inhibiting the NF-κB and interferon pathways.

Chen S, Bonifati S, Qin Z, St Gelais C, Kodigepalli KM, Barrett BS, Kim SH, Antonucci JM, Ladner KJ, Buzovetsky O, Knecht KM, Xiong Y, Yount JS, Guttridge DC, Santiago ML, Wu L.

Proc Natl Acad Sci U S A. 2018 Apr 17;115(16):E3798-E3807. doi: 10.1073/pnas.1801213115. Epub 2018 Apr 2.

7.

Human Papillomavirus 16 E7 Stabilizes APOBEC3A Protein by Inhibiting Cullin 2-Dependent Protein Degradation.

Westrich JA, Warren CJ, Klausner MJ, Guo K, Liu CW, Santiago ML, Pyeon D.

J Virol. 2018 Mar 14;92(7). pii: e01318-17. doi: 10.1128/JVI.01318-17. Print 2018 Apr 1.

8.

Latest Advances in Ultrasound Assessment of Salivary Glands in Sjögren Syndrome.

Martire MV, Santiago ML, Cazenave T, Gutierrez M.

J Clin Rheumatol. 2018 Jun;24(4):218-223. doi: 10.1097/RHU.0000000000000625.

PMID:
29239938
9.

Breaching peripheral tolerance promotes the production of HIV-1-neutralizing antibodies.

Schroeder KMS, Agazio A, Strauch PJ, Jones ST, Thompson SB, Harper MS, Pelanda R, Santiago ML, Torres RM.

J Exp Med. 2017 Aug 7;214(8):2283-2302. doi: 10.1084/jem.20161190. Epub 2017 Jul 11.

10.

Follicular Regulatory T Cells Are Highly Permissive to R5-Tropic HIV-1.

Miller SM, Miles B, Guo K, Folkvord J, Meditz AL, McCarter MD, Levy DN, MaWhinney S, Santiago ML, Connick E.

J Virol. 2017 Aug 10;91(17). pii: e00430-17. doi: 10.1128/JVI.00430-17. Print 2017 Sep 1.

11.

Type I interferon signaling is required for the APOBEC3/Rfv3-dependent neutralizing antibody response but not innate retrovirus restriction.

Barrett BS, Harper MS, Jones ST, Guo K, Heilman KJ, Kedl RM, Hasenkrug KJ, Santiago ML.

Retrovirology. 2017 Apr 17;14(1):25. doi: 10.1186/s12977-017-0349-2.

12.

Impaired B cell function during viral infections due to PTEN-mediated inhibition of the PI3K pathway.

Getahun A, Wemlinger SM, Rudra P, Santiago ML, van Dyk LF, Cambier JC.

J Exp Med. 2017 Apr 3;214(4):931-941. doi: 10.1084/jem.20160972. Epub 2017 Mar 24.

13.

The transcriptome of HIV-1 infected intestinal CD4+ T cells exposed to enteric bacteria.

Yoder AC, Guo K, Dillon SM, Phang T, Lee EJ, Harper MS, Helm K, Kappes JC, Ochsenbauer C, McCarter MD, Wilson CC, Santiago ML.

PLoS Pathog. 2017 Feb 27;13(2):e1006226. doi: 10.1371/journal.ppat.1006226. eCollection 2017 Feb.

14.

Low abundance of colonic butyrate-producing bacteria in HIV infection is associated with microbial translocation and immune activation.

Dillon SM, Kibbie J, Lee EJ, Guo K, Santiago ML, Austin GL, Gianella S, Landay AL, Donovan AM, Frank DN, McCARTER MD, Wilson CC.

AIDS. 2017 Feb 20;31(4):511-521. doi: 10.1097/QAD.0000000000001366.

15.

T Cell Production of IFNγ in Response to TLR7/IL-12 Stimulates Optimal B Cell Responses to Viruses.

Rubtsova K, Rubtsov AV, Halemano K, Li SX, Kappler JW, Santiago ML, Marrack P.

PLoS One. 2016 Nov 23;11(11):e0166322. doi: 10.1371/journal.pone.0166322. eCollection 2016.

16.

A chimeric human APOBEC3A protein with a three amino acid insertion confers differential HIV-1 and adeno-associated virus restriction.

Wang Y, Wang Z, Pramanik A, Santiago ML, Qiu J, Stephens EB.

Virology. 2016 Nov;498:149-163. doi: 10.1016/j.virol.2016.08.001. Epub 2016 Aug 30.

17.

Interferon Alpha Subtype-Specific Suppression of HIV-1 Infection In Vivo.

Lavender KJ, Gibbert K, Peterson KE, Van Dis E, Francois S, Woods T, Messer RJ, Gawanbacht A, Müller JA, Münch J, Phillips K, Race B, Harper MS, Guo K, Lee EJ, Trilling M, Hengel H, Piehler J, Verheyen J, Wilson CC, Santiago ML, Hasenkrug KJ, Dittmer U.

J Virol. 2016 Jun 10;90(13):6001-6013. doi: 10.1128/JVI.00451-16. Print 2016 Jul 1.

18.

Tetherin/BST-2: Restriction Factor or Immunomodulator?

Li SX, Barrett BS, Guo K, Santiago ML.

Curr HIV Res. 2016;14(3):235-46. Review.

19.

Tetherin/BST-2 promotes dendritic cell activation and function during acute retrovirus infection.

Li SX, Barrett BS, Guo K, Kassiotis G, Hasenkrug KJ, Dittmer U, Gibbert K, Santiago ML.

Sci Rep. 2016 Feb 5;6:20425. doi: 10.1038/srep20425.

20.

Enhancement of HIV-1 infection and intestinal CD4+ T cell depletion ex vivo by gut microbes altered during chronic HIV-1 infection.

Dillon SM, Lee EJ, Donovan AM, Guo K, Harper MS, Frank DN, McCarter MD, Santiago ML, Wilson CC.

Retrovirology. 2016 Jan 14;13:5. doi: 10.1186/s12977-016-0237-1.

21.

Interferon-α Subtypes in an Ex Vivo Model of Acute HIV-1 Infection: Expression, Potency and Effector Mechanisms.

Harper MS, Guo K, Gibbert K, Lee EJ, Dillon SM, Barrett BS, McCarter MD, Hasenkrug KJ, Dittmer U, Wilson CC, Santiago ML.

PLoS Pathog. 2015 Nov 3;11(11):e1005254. doi: 10.1371/journal.ppat.1005254. eCollection 2015.

22.

Role of the single deaminase domain APOBEC3A in virus restriction, retrotransposition, DNA damage and cancer.

Wang Y, Schmitt K, Guo K, Santiago ML, Stephens EB.

J Gen Virol. 2016 Jan;97(1):1-17. doi: 10.1099/jgv.0.000320. Epub 2015 Oct 20. Review.

23.

Immunoglobulin VH gene diversity and somatic hypermutation during SIV infection of rhesus macaques.

Guo K, Halemano K, Schmitt K, Katuwal M, Wang Y, Harper MS, Heilman KJ, Kuwata T, Stephens EB, Santiago ML.

Immunogenetics. 2015 Jul;67(7):355-70. doi: 10.1007/s00251-015-0844-3. Epub 2015 May 21.

24.

Requirement for Fc effector mechanisms in the APOBEC3/Rfv3-dependent neutralizing antibody response.

Halemano K, Barrett BS, Heilman KJ, Morrison TE, Santiago ML.

J Virol. 2015 Apr;89(7):4011-4. doi: 10.1128/JVI.03399-14. Epub 2015 Jan 14.

25.

Usefulness of antibodies and minor salivary gland biopsy in the study of sicca syndrome in daily clinical practice.

Santiago ML, Seisdedos MR, Garcia Salinas RN, Catalán Pellet A, Villalón L, Secco A.

Reumatol Clin. 2015 May-Jun;11(3):156-60. doi: 10.1016/j.reuma.2014.06.004. Epub 2015 Jan 9.

26.

Friend retrovirus drives cytotoxic effectors through Toll-like receptor 3.

Gibbert K, Francois S, Sigmund AM, Harper MS, Barrett BS, Kirchning CJ, Lu M, Santiago ML, Dittmer U.

Retrovirology. 2014 Dec 24;11:126. doi: 10.1186/s12977-014-0126-4.

27.

Compartmentalization of simian immunodeficiency virus replication within secondary lymphoid tissues of rhesus macaques is linked to disease stage and inversely related to localization of virus-specific CTL.

Connick E, Folkvord JM, Lind KT, Rakasz EG, Miles B, Wilson NA, Santiago ML, Schmitt K, Stephens EB, Kim HO, Wagstaff R, Li S, Abdelaal HM, Kemp N, Watkins DI, MaWhinney S, Skinner PJ.

J Immunol. 2014 Dec 1;193(11):5613-25. doi: 10.4049/jimmunol.1401161. Epub 2014 Oct 31.

28.

APOBEC3A functions as a restriction factor of human papillomavirus.

Warren CJ, Xu T, Guo K, Griffin LM, Westrich JA, Lee D, Lambert PF, Santiago ML, Pyeon D.

J Virol. 2015 Jan;89(1):688-702. doi: 10.1128/JVI.02383-14. Epub 2014 Oct 29.

29.

Reassessment of murine APOBEC1 as a retrovirus restriction factor in vivo.

Barrett BS, Guo K, Harper MS, Li SX, Heilman KJ, Davidson NO, Santiago ML.

Virology. 2014 Nov;468-470:601-608. doi: 10.1016/j.virol.2014.09.006. Epub 2014 Oct 7.

30.

Cellular HIV-1 inhibition by truncated old world primate APOBEC3A proteins lacking a complete deaminase domain.

Katuwal M, Wang Y, Schmitt K, Guo K, Halemano K, Santiago ML, Stephens EB.

Virology. 2014 Nov;468-470:532-544. doi: 10.1016/j.virol.2014.09.001. Epub 2014 Sep 28.

31.

Tetherin promotes the innate and adaptive cell-mediated immune response against retrovirus infection in vivo.

Li SX, Barrett BS, Heilman KJ, Messer RJ, Liberatore RA, Bieniasz PD, Kassiotis G, Hasenkrug KJ, Santiago ML.

J Immunol. 2014 Jul 1;193(1):306-16. doi: 10.4049/jimmunol.1400490. Epub 2014 May 28.

32.

Inhibitory effects of Baccharis dracunculifolia on 1,2-dimethylhidrazine-induced genotoxicity and preneoplastic lesions in rat colon.

Munari CC, Furtado RA, Santiago ML, Manhas SS, Bastos JK, Tavares DC.

Eur J Cancer Prev. 2014 Jul;23(4):240-5. doi: 10.1097/CEJ.0000000000000039.

PMID:
24871557
33.

Immunoglobulin somatic hypermutation by APOBEC3/Rfv3 during retroviral infection.

Halemano K, Guo K, Heilman KJ, Barrett BS, Smith DS, Hasenkrug KJ, Santiago ML.

Proc Natl Acad Sci U S A. 2014 May 27;111(21):7759-64. doi: 10.1073/pnas.1403361111. Epub 2014 May 12.

34.

Microbial exposure alters HIV-1-induced mucosal CD4+ T cell death pathways Ex vivo.

Steele AK, Lee EJ, Manuzak JA, Dillon SM, Beckham JD, McCarter MD, Santiago ML, Wilson CC.

Retrovirology. 2014 Feb 4;11:14. doi: 10.1186/1742-4690-11-14.

35.

Enhanced fusion and virion incorporation for HIV-1 subtype C envelope glycoproteins with compact V1/V2 domains.

Cavrois M, Neidleman J, Santiago ML, Derdeyn CA, Hunter E, Greene WC.

J Virol. 2014 Feb;88(4):2083-94. doi: 10.1128/JVI.02308-13. Epub 2013 Dec 11.

36.

Ribonuclease L is not critical for innate restriction and adaptive immunity against Friend retrovirus infection.

Li SX, Barrett BS, Harper MS, Heilman KJ, Halemano K, Steele AK, Guo K, Silverman RH, Santiago ML.

Virology. 2013 Aug 15;443(1):134-42. doi: 10.1016/j.virol.2013.05.009. Epub 2013 May 29.

37.

Lentivirus restriction by diverse primate APOBEC3A proteins.

Schmitt K, Guo K, Katuwal M, Wilson D, Prochnow C, Bransteitter R, Chen XS, Santiago ML, Stephens EB.

Virology. 2013 Jul 20;442(1):82-96. doi: 10.1016/j.virol.2013.04.002. Epub 2013 May 4.

38.

Fv1 restriction and retrovirus vaccine immunity in Apobec3-deficient 129P2 mice.

Halemano K, Barrett BS, Li SX, Harper MS, Smith DS, Heilman KJ, Santiago ML.

PLoS One. 2013;8(3):e60500. doi: 10.1371/journal.pone.0060500. Epub 2013 Mar 22.

39.

IFN-α treatment inhibits acute Friend retrovirus replication primarily through the antiviral effector molecule Apobec3.

Harper MS, Barrett BS, Smith DS, Li SX, Gibbert K, Dittmer U, Hasenkrug KJ, Santiago ML.

J Immunol. 2013 Feb 15;190(4):1583-90. doi: 10.4049/jimmunol.1202920. Epub 2013 Jan 11.

40.

Distinct evolutionary pressures underlie diversity in simian immunodeficiency virus and human immunodeficiency virus lineages.

Fischer W, Apetrei C, Santiago ML, Li Y, Gautam R, Pandrea I, Shaw GM, Hahn BH, Letvin NL, Nabel GJ, Korber BT.

J Virol. 2012 Dec;86(24):13217-31. doi: 10.1128/JVI.01862-12. Epub 2012 Oct 10.

41.

Humoral immunity in the Friend retrovirus infection model.

Halemano K, Harper MS, Guo K, Li SX, Heilman KJ, Barrett BS, Santiago ML.

Immunol Res. 2013 Mar;55(1-3):249-60. doi: 10.1007/s12026-012-8370-y. Review.

42.

A single nucleotide polymorphism in tetherin promotes retrovirus restriction in vivo.

Barrett BS, Smith DS, Li SX, Guo K, Hasenkrug KJ, Santiago ML.

PLoS Pathog. 2012;8(3):e1002596. doi: 10.1371/journal.ppat.1002596. Epub 2012 Mar 22.

43.

Noninfectious retrovirus particles drive the APOBEC3/Rfv3 dependent neutralizing antibody response.

Smith DS, Guo K, Barrett BS, Heilman KJ, Evans LH, Hasenkrug KJ, Greene WC, Santiago ML.

PLoS Pathog. 2011 Oct;7(10):e1002284. doi: 10.1371/journal.ppat.1002284. Epub 2011 Oct 6.

44.

Differential virus restriction patterns of rhesus macaque and human APOBEC3A: implications for lentivirus evolution.

Schmitt K, Guo K, Algaier M, Ruiz A, Cheng F, Qiu J, Wissing S, Santiago ML, Stephens EB.

Virology. 2011 Oct 10;419(1):24-42. doi: 10.1016/j.virol.2011.07.017. Epub 2011 Aug 25.

45.

Negative addiction to exercise: are there differences between genders?

Modolo VB, Antunes HK, Gimenez PR, Santiago ML, Tufik S, Mello MT.

Clinics (Sao Paulo). 2011;66(2):255-60.

46.

Abortive HIV infection mediates CD4 T cell depletion and inflammation in human lymphoid tissue.

Doitsh G, Cavrois M, Lassen KG, Zepeda O, Yang Z, Santiago ML, Hebbeler AM, Greene WC.

Cell. 2010 Nov 24;143(5):789-801. doi: 10.1016/j.cell.2010.11.001. Erratum in: Cell. 2014 Feb 27;156(5):1112-3.

47.

Persistent Friend virus replication and disease in Apobec3-deficient mice expressing functional B-cell-activating factor receptor.

Santiago ML, Smith DS, Barrett BS, Montano M, Benitez RL, Pelanda R, Hasenkrug KJ, Greene WC.

J Virol. 2011 Jan;85(1):189-99. doi: 10.1128/JVI.01838-10. Epub 2010 Oct 27.

48.

The glycosylated Gag protein of a murine leukemia virus inhibits the antiretroviral function of APOBEC3.

Kolokithas A, Rosenke K, Malik F, Hendrick D, Swanson L, Santiago ML, Portis JL, Hasenkrug KJ, Evans LH.

J Virol. 2010 Oct;84(20):10933-6. doi: 10.1128/JVI.01023-10. Epub 2010 Aug 11.

49.

Innate retroviral restriction by Apobec3 promotes antibody affinity maturation in vivo.

Santiago ML, Benitez RL, Montano M, Hasenkrug KJ, Greene WC.

J Immunol. 2010 Jul 15;185(2):1114-23. doi: 10.4049/jimmunol.1001143. Epub 2010 Jun 21.

50.

Effective activation alleviates the replication block of CCR5-tropic HIV-1 in chimpanzee CD4+ lymphocytes.

Decker JM, Zammit KP, Easlick JL, Santiago ML, Bonenberger D, Hahn BH, Kutsch O, Bibollet-Ruche F.

Virology. 2009 Nov 10;394(1):109-18. doi: 10.1016/j.virol.2009.08.027. Epub 2009 Sep 12.

Supplemental Content

Loading ...
Support Center